Renal cell carcinoma
Is partial nephrectomy a better surgical option for the treatment of renal cell carcinoma?
Biomarker test developed for rare form of renal cancer
High blood pressure may act as sunitinib efficacy biomarker in metastatic renal cell carcinoma patients
Advanced kidney cancer risk increased by heavy smoking, study suggests
Axitinib could boost progression-free survival in renal cell cancer, Phase III study suggests
TKI treatment may improve overall survival and decrease metastasis in renal cell carcinoma patients
Cytokine therapy for renal cell cancer
mTOR inhibitors in renal cell carcinoma
Therapeutic vaccines in renal cell carcinoma
New study suggests drug affects negative memories
US FDA approves fidaxomicin for the treatment of Clostridium difficile -associated diarrhea
Bavarian Nordic announces data from trial of vaccine for patients with locally recurrent prostate cancer
Adalimumab and methotrexate combination could improve disease control for early-stage rheumatoid arthritis patients
Early study demonstrates promising results for novel injectable back pain solution
Drug Approvals April 2011 to June 2011.
Drospirenone and its linkage to venous thrombosis
The STICH trial and coronary revascularization
The emergence of excellence in adjunctive antiplatelet therapy
Bivalirudin
Certolizumab pegol for the treatment of rheumatoid arthritis
Update on vascular disrupting agents for cancer therapy
Current treatment options for elderly patients with multiple myeloma
Long-term effects of inhaled bronchodilators in stable chronic obstructive pulmonary disease
Sublingual immunotherapy with natural grass pollen extracts
Acknowledgements